Relevium forms JV with Holistic to develop Biocannabix

Relevium forms JV with Holistic to develop Biocannabix

MONTREAL, QUEBEC -- November 16, 2018 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”)

Mr. Aurelio Useche reports

RELEVIUM TECHNOLOGIES SIGNS JV WITH HOLISTIC INDUSTRIES FOR BIOCANNABIX HEALTH CORPORATION

Relevium Technologies Inc. has executed a letter of intent to form a partnership with Holistic Industries to jointly develop Biocannabix Health Corp., the pediatric and geriatric focused biopharma subsidiary of Relevium Technologies.

"We are very pleased to partner with one the pioneers and leaders in medical cannabis in the U.S. The win-win strategy of leveraging the many years of experience from Holistic in growing and processing will allow the company to focus on research and product development dramatically shortening the development cycle and enabling the company to provide real medicine faster to patients in need," said Aurelio Useche, chief executive officer.

"Holistic is very excited to partner with Relevium on the development of Biocannabix Health Corp. and explore the possibilities to develop products and intellectual property for the benefit of pediatric and geriatric patients who need it most. The combination of existing applications by our company and that from CK Properties, combined with the know-how in nutraceutical formulations and oils in Canada will open the doors to both companies internationally," said Rick Genderson, chairman of Holistic Industries.

Background

On April 19, 2018, Relevium announced its intention to enter the medical cannabis market through its wholly owned subsidiary Biocannabix Health and in mid-May, the company engaged Pipedreemz Consultants to begin the process of applying to Health Canada to get fully licensed to operate in the legal medical cannabis market. On July 19, 2018, the company obtained the approval by municipal authorities to establish a medical cannabis biopharma on the selected 93,000-square-foot facility located in Montreal, Que.

The objective that management set out for Biocannabix is to build a fully integrated biopharma company with control over plant genetics by growing specialized organic cannabis strains, ensuring the best process to extract the purest and safest form of cannabis concentrates and develop a true understanding, at the molecular level, about the beneficial use, formulation and dosage for pediatric and geriatric applications.

As part of this objective, on Oct. 16, 2018, the company announced it was obtaining the exclusive licence for the formulations, standard operating procedures and research data from CK Properties and Cannakids, a U.S.-based organization specialized in research and direct medical applications of its products for pediatric and geriatric purposes.

Partnership with Holistic Industries and potential spinoff

Holistic Industries brings to Biocannabix five years of successful cannabis experience and it is one of the pioneers of the industry in the U.S. The company is licensed in four states and the district of Columbia to grow, process, develop and retail top-quality and safe medical products to the market.

Holistic Industries major contributions are expected to include knowledge transfer for growing organically, management of genetic strains for specific health purposes, processing technology as well as existing formulations from their trusted Liberty product portfolio. Although a definitive agreement is only expected within the next 60 days, both companies are already co-operating in the design and capability development of the facilities in Montreal.

Biocannabix Health is being structured to be a leading biopharma company focused on research and development of cannabis-derived nutraceuticals, pharmaceuticals and medicinal foods. In order to ensure focus and support maximum value creation for shareholders, Relevium is considering the eventual spinoff of Biocannabix as a focused and separate publicly traded company.

About Relevium Technologies Inc.

Relevium is a publicly traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on on-line distribution. The principal business of the company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets and medical cannabis. The company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products.

We seek Safe Harbor.

Relevium Technologies (CE) (USOTC:RLLVF)
Historical Stock Chart
From Mar 2024 to Apr 2024